GEN Exclusives

More »

GEN News Highlights

More »
Aug 18, 2008

Thermo Fisher Scientific Teams Up with Toronto University for Cancer Proteomics Research

  • Thermo Fisher Scientific is collaborating with the University Health Network (UHN) related to cancer biomarker development. The UHN team will use the company’s LTQ Orbitrap™ and Quantum Ultra™ mass spectrometry systems.

    Thermo Fisher Scientific and the UHN will also maintain a cross-validation workflow to help legitimize new biomarkers. After the UHN team validates a cancer biomarker, they will send it to the Thermo Fisher Scientific Biomarker Research Initiatives in Mass Spectrometry Center for a second validation.

    The researchers will look for proteins in the secreted fluids of cancer cell lines. The partners believe that this approach will accelerate the validation of biomarkers, targeted assays, and ultimately the development of blood tests.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?